Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.

[1]  D. Grönemeyer,et al.  Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study. , 2013, Atherosclerosis.

[2]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[3]  O. Alfieri,et al.  [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. , 2013, Giornale italiano di cardiologia.

[4]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[5]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[6]  P. Tsao,et al.  Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. , 2012, Journal of the American College of Cardiology.

[7]  Anne Tybjærg-Hansen,et al.  Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[8]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[9]  A. Gotlieb,et al.  The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[10]  Alec Vahanian,et al.  Epidemiology of valvular heart disease in the adult , 2011, Nature Reviews Cardiology.

[11]  J. Borén,et al.  Lipoprotein(a) as a cardiovascular risk factor: current status , 2010, European heart journal.

[12]  P. R. Kamstrup.  Lipoprotein(a) and ischemic heart disease--a causal association? A review. , 2010, Atherosclerosis.

[13]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[14]  Stephen Kaptoge,et al.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.

[15]  Børge G Nordestgaard,et al.  Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. , 2009, JAMA.

[16]  B. Nordestgaard,et al.  Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. , 2008, Circulation.

[17]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[18]  B. Nordestgaard,et al.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. , 2007, JAMA.

[19]  A. Yıldırır,et al.  Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification. , 2007, The Journal of heart valve disease.

[20]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[21]  W. Roberts,et al.  Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.

[22]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[23]  P. Saikku,et al.  Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. , 2003, European heart journal.

[24]  P. Schnohr.  The Copenhagen City Heart Study : Østerbroundersøgelsen : tables with data from the third examination 1991-1994 , 2001 .

[25]  R. Collins,et al.  Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.

[26]  A. Noma,et al.  Immunolocalization of Lipoprotein(a) in Wounded Tissues , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[28]  C. Otto,et al.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[29]  B. Nordestgaard,et al.  Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo. , 1996, Circulation research.

[30]  T. Mitsuhashi,et al.  Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). , 1995, The American journal of cardiology.

[31]  A. del Río.  [Lipoprotein (a)]. , 1991, Medicina clinica.

[32]  J. Goldstein,et al.  Teaching old dogmas new tricks , 1987, Nature.

[33]  M. Brown,et al.  Plasma lipoproteins: teaching old dogmas new tricks. , 1987, Nature.